Guosa Life Sciences (GLS) is a global Contract Research Organization (CRO) delivering integrated clinical development solutions across established and emerging markets worldwide. We support Phase I–IV clinical programs for pharmaceutical, biotechnology, vaccine, medical device, academic, government, and public health organizations through scientific expertise, operational agility, regulatory intelligence, and quality-driven clinical execution.
To accelerate the development of innovative therapies and healthcare solutions by delivering high-quality, globally compliant clinical research services through scientific rigor, operational excellence, and trusted global expertise.
To become a globally recognized CRO and trusted strategic partner known for scientific integrity, operational excellence, and successful clinical trial execution across established and emerging markets worldwide.
We deliver high-quality, inspection-ready clinical research aligned with global regulatory standards.
We operate with transparency, professionalism, and uncompromising ethical standards.
We leverage technology, data-driven strategies, and operational agility to improve clinical development performance.
We work closely with sponsors, investigators, regulators, healthcare institutions, and communities to achieve shared success.
We combine global standards with regional expertise to support efficient and culturally informed clinical trial execution worldwide.
We prioritize patient safety, diversity, accessibility, and responsible community engagement throughout the clinical research process.
At GLS, we believe clinical research must be both globally rigorous and locally relevant. Successful clinical development requires scientific expertise, strategic execution, regulatory insight, and agile operational delivery across increasingly complex healthcare environments.
Our approach is built on three core principles:
Inspection ready quality systems and globally aligned processes designed to support compliant, reliable clinical research.
Responsive operational execution supported by disciplined oversight, quality governance, and patient safety.
Strengthening research infrastructure and increasing participation across diverse and underrepresented populations to support broader, more inclusive clinical evidence generation.
GLS is committed to serving as a long-term strategic partner that helps sponsors reduce risk, improve efficiency, and successfully advance clinical programs worldwide through integrated scientific, operational, regulatory, and quality solutions.